A blinded, randomized and controlled multicenter clinical trial to assess the efficacy and safety of Leisguard(®) as an immunotherapeutic treatment for healthy Leishmania infantum-seropositive dogs

BACKGROUND: Domperidone (Leisguard(®)) is an immunomodulatory drug used as a preventive measure in healthy dogs. However, no studies have been published in healthy Leishmania infantum-seropositive dogs. The aim of this study was to evaluate the clinical efficacy and safety of domperidone as immunoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxarias, Marta, Donato, Giulia, Mateu, Cristina, Salichs, Marta, Homedes, Josep, Miró, Guadalupe, Pennisi, Maria Grazia, Solano-Gallego, Laia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552330/
https://www.ncbi.nlm.nih.gov/pubmed/37794502
http://dx.doi.org/10.1186/s13071-023-05903-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552330/
https://www.ncbi.nlm.nih.gov/pubmed/37794502
http://dx.doi.org/10.1186/s13071-023-05903-0

Ejemplares similares